STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
UMC Utrecht
xCures
Adela, Inc
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Vanderbilt University Medical Center
UNC Lineberger Comprehensive Cancer Center
Eli Lilly and Company
St. Jude Children's Research Hospital
Maastricht Radiation Oncology
LigaChem Biosciences, Inc.
Aalborg University Hospital
Washington University School of Medicine
RefleXion Medical
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Incyte Corporation
CNAO National Center of Oncological Hadrontherapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Columbia University
Tempus AI
Thomas Jefferson University
Thomas Jefferson University
Cedars-Sinai Medical Center
Sheffield Teaching Hospitals NHS Foundation Trust
Algemeen Ziekenhuis Maria Middelares
University of Michigan Rogel Cancer Center
Aminex Therapeutics, Inc.
The New York Proton Center
Washington University School of Medicine
University of Sydney
Cedars-Sinai Medical Center
Washington University School of Medicine
Mayo Clinic
P-Cure
Eastern Cooperative Oncology Group
Sunnybrook Health Sciences Centre
Rigshospitalet, Denmark
Quadriga Biosciences, Inc.
Technische Universität Dresden
Dana-Farber Cancer Institute
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
University of California, San Francisco
Hospices Civils de Lyon
Albert Einstein College of Medicine
SpeciCare
Massachusetts General Hospital
University Hospital Tuebingen
Tocagen Inc.